Lexicon Pharmaceuticals | LXRX - Eps Utile Per Azione





Eps Cambiamento Data
Abbott USD 1.31 0.16 2026-06
Acadia Pharmaceuticals USD 0.02 1.58 2026-03
Agios Pharmaceuticals USD -1.69 0 2026-06
Akebia Therapeutics USD -0.04 0.04 2025-12
Alnylam Pharmaceuticals USD 1.84 0.15 2026-06
AstraZeneca USD 2.63 0.05 2026-06
BioMarin Pharmaceutical USD 0.76 0.3 2026-03
Coherus Biosciences USD -0.43 0.06 2025-12
Eli Lilly USD 8.55 1.01 2026-03
Halozyme Therapeutics USD 1.6 1.84 2026-03
Illumina USD 1.31 0.16 2026-06
Insmed USD -0.76 0.78 2026-03
Ironwood Pharmaceuticals USD 0.24 0.25 2026-03
J&J USD 2.9 0.2 2026-06
Lexicon Pharmaceuticals USD -0.04 0.01 2025-12
MacroGenics USD -0.58 0.36 2026-03
MannKind USD -0.02 0.03 2026-03
Merck USD -1.28 3.32 2026-03
Moderna USD -3.4 1.29 2026-03
Novartis USD 2.41 0.42 2026-06
PTC Therapeutics USD 0.92 0.95 2026-06
Puma Biotechnology USD 0.41 0.5 2024-09
Sarepta Therapeutics USD 3.16 6.74 2026-03
Thermo Fisher Scientific USD 6.03 0.59 2026-06
Ultragenyx Pharmaceutical USD -1.84 0.55 2026-03
United Therapeutics USD 5.82 1.88 2026-03
Vanda Pharmaceuticals USD -0.09 0 2024-12